beta
IA Trial Radar

Mostrando estudos clínicos para glp1 Agonist.

Posso ajudar você a entender condições de saúde, tratamentos ou encontrar estudos clínicos próximos.
Nossa ferramenta de busca suporta apenas o inglês. Para pesquisa e discussão em outros idiomas, use a IA Trial Radar acima ou selecione filtros de condições médicas e locais abaixo.
99 resultados
Mostrando os 50 primeiros
 
Status (Padrão)
Ainda Não Recrutando, Em Recrutamento, Ativo, Não Recrutando
×
 
Condição médica
glp1 Agonist
×
 
Intervenção
GLP-1
×
 
Título do estudo
Status
Effect of Agonist GLP1 on Adipose Tissue in Patients Undergoing Bariatric Surgery (Maigrir_OT) NCT06278285
Em recrutamento
Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists NCT07224880
Em recrutamento
GLP-1 RA on Liver OMICS in MASLD NCT06982378
Ainda não recrutando
Bone Metabolism in 12-21 Year Olds Undergoing GLP-1 Receptor Agonist Therapy NCT06903923
Em recrutamento
Impact GLP-1 Agonists Following Bariatric NCT06132477
Em recrutamento
Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer NCT07314528
Ainda não recrutando
The Impact of GLP Medication on Colonoscopy Bowel Preparation Quality NCT07127354
Em recrutamento
Protective Benefits of a Clear Liquid Diet on Residual Gastric Content in Patients Taking Glucagon Like Peptide-1 Receptor (GLP-1 RA) Agonist Prior to Anesthesia NCT06654219
Em recrutamento
Effects of Beginning a GLP1-Agonist Therapy on Residual Gastric Content and Gastric Emptying (GLP-1) NCT06659159
Ainda não recrutando
Effect of GLP-1 Receptor Agonists on Body Composition in Obesity: The Role of Dietary Protein Consumption in Muscle Mass Maintenance (LEAN-PRO GLP-1) NCT07495904
Em recrutamento
Gastric Emptying in Healthy Volunteers and GLP-1 Agonist Users (aGLP1-GUS) NCT06987669
Ainda não recrutando
Restoring Facial Volume After GLP-1 Weight Loss With Radiesse NCT07419854
Em recrutamento
Gastric Emptying With Metoclopramide in GLP-1 Agonist Patients Undergoing Elective Surgery (GEM-GLP1RA) NCT07100691
Ainda não recrutando
Strength Training Response of Muscle in GLP-1 Users (STRONG-GLP) NCT07104539
Em recrutamento
Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness NCT06487832
Em recrutamento
Pelvic Floor Disorder Symptoms in Women Seeking Weight Loss Therapy NCT07175805
Ainda não recrutando
Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists NCT07325435
Ativo, não recrutando
Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions (COMO-1) NCT06867718
Ativo, não recrutando
Evaluate the Detection of Retained Gastric Contents and Assess Safety Using the Flower Capsule Endoscopy in Healthy Individuals and GLP-1 Receptor Agonist Users NCT06927401
Ainda não recrutando
Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS) NCT07169136
Em recrutamento
Menopausal Hormone Therapy, GLP-1 Agonists, and Glucose and Energy Homeostasis in Postmenopausal Women With Diabetes (DECLARED-CT) NCT06715514
Em recrutamento
Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity NCT07091500
Em recrutamento
Effect of Weekly GLP1 Agonist Treatment in "Double Diabetes" (TOLEDDO) NCT05305794
Em recrutamento
GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance NCT04731272
Em recrutamento
Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment NCT06069622
Em recrutamento
A Study of a Weight Loss Intervention in People With Endometrial Cancer NCT06751589
Em recrutamento
Probiotic Intervention for Digestive Health in Obese Patients Initiating GLP-RA Treatment (PROBIO-GLP1) NCT07213323
Ainda não recrutando
Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity (PLASTIC) NCT07021937
Ainda não recrutando
Gastric POCUS for Airway Management in Patients Using Glucagon-like Peptide-1 Receptor Agonist NCT06666049
Em recrutamento
Comparison of Body Composition Changes With Weight Loss Interventions (REFORM) NCT07115069
Em recrutamento
The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination NCT03878706
Em recrutamento
Testing the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss. (OBA) NCT07411378
Ainda não recrutando
Direct Measurement of Microstructure of Ingestive Behaviour After Initiation of GLP-1 Receptor Agonist Treatment at Maximum Dose (DIGRAT) NCT07457424
Ativo, não recrutando
CRAVE Study: Comparing Craving Responses and Diet Quality of GLP1 Receptor Agonist Users NCT06467604
Ativo, não recrutando
GLP-1 and Hyperoxia for Organ Protection in Heart Surgery (GLORIOUS) NCT02673931
Ativo, não recrutando
Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass (GLIMMER) NCT07272837
Ainda não recrutando
GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study) NCT07083154
Em recrutamento
Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity (SEMAMOOD) NCT07136714
Em recrutamento
Digital Behavioral Therapy to Reduce Diabetes and Liver Disease Risk (SIPPA-QH_HHC-2) NCT07032311
Ainda não recrutando
Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis (RADIANT) NCT07282041
Em recrutamento
Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients NCT06774079
Em recrutamento
GLP-1 Receptor Agonist for Reduction of Myocardial Injury After Non-cardiac Surgery (GLUMINS) NCT06324461
Em recrutamento
Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of a GLP-1 Receptor Agonist Semaglutide in U.S. Veterans With Alcohol Use Disorder (CRAVE) NCT07218354
Ainda não recrutando
Study of BMF-650 in Otherwise Healthy Overweight or Obese Adult Participants NCT07223216
Em recrutamento
A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia NCT07107334
Em recrutamento
Body Composition and Exercise to Prevent Muscle Loss With GLP1 Agonist Treatment (BICEP) NCT07226947
Em recrutamento
Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes NCT06706284
Em recrutamento
Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss (PLATEAU) NCT07446998
Em recrutamento
Weight Loss Management in Endometrial Cancer Survivors (ECS Weight) NCT06877572
Em recrutamento
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US NCT07431086
Em recrutamento